Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. April 2013 08:01 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis Presented at EASL

NEW YORK, April 30, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel...
25. April 2013 16:50 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals to Present at Upcoming Healthcare Conferences

NEW YORK, April 25, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
08. April 2013 08:01 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Upcoming EASL Presentation

NEW YORK, April 8, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel...
18. März 2013 16:30 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces 2012 Financial Results and Provides Business Update

Continued Development Progress and a Strong Cash Position Conference Call Scheduled Today at 5:30 p.m. ET NEW YORK, March 18, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals,...
12. März 2013 06:00 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 18

NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
04. März 2013 08:08 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer

NEW YORK, March 4, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
25. Februar 2013 17:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals to Present at the Cowen and Company 33rd Annual Healthcare Conference

NEW YORK, Feb. 25, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
07. Februar 2013 17:19 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals to Present at Leerink Swann 2013 Global Healthcare Conference

NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
07. Januar 2013 17:35 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Initiation of Phase 2 NASH Trial of OCA in Japan

NEW YORK, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...
19. Dezember 2012 07:05 ET | Quelle: Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Announces Completion of Enrollment in Phase 3 Primary Biliary Cirrhosis POISE Trial

NEW YORK, Dec. 19, 2012 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...

Vorherige Seite